19 June 2013
Keywords: s-p, files, nda, rebetol, plus, intron-a, schering-plough
Article | 11 December 1997
- Schering-Plough has filed a New Drug Application with the USregulatory authorities for approval to market Rebetol (ribavirin), which is licensed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.